Profile data is unavailable for this security.
About the company
Precipio, Inc. is a healthcare biotechnology company that is focused on cancer diagnostics. It develops and sells diagnostic products, reagents and services that improve the accuracy and efficiency of diagnostics, and lead to fewer misdiagnoses. The Company’s technologies include HemeScreen and IV-Cell. IV-Cell is a cell culture media that addresses the problem of diagnostic mistakes through the process of selective culturing. IV-Cell is a universal media that enables simultaneous culturing of all four hematopoietic cell lineages. Its technology enables testing to be completed in one rapid scanning process. The HemeScreen panels test for the presence of various mutations. In developing HemeScreen, it focused on improving the economics of providing blood cancer diagnostic tests and reducing laboratory technician time consumed in the testing process. The Company’s laboratory and research and development (R&D) facilities are located in New Haven, Connecticut and Omaha, Nebraska.
- Revenue in USD (TTM)16.72m
- Net income in USD-3.83m
- Incorporated1997
- Employees51.00
- LocationPrecipio Inc4 Science ParkNEW HAVEN 06511United StatesUSA
- Phone+1 (203) 787-7888
- Fax+1 (302) 655-5049
- Websitehttp://www.precipiodx.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Caduceus Software Systems Corp | 0.00 | -117.60k | 7.17m | 0.00 | -- | -- | -- | -- | -0.0004 | -0.0004 | 0.00 | -0.0004 | 0.00 | -- | -- | -- | -402.19 | -11,090.31 | -- | -- | -- | -- | -- | -- | -- | -76.88 | -- | -- | -- | -- | -20,519.89 | -- | -- | -- |
Biotricity Inc | 12.24m | -18.28m | 7.19m | 55.00 | -- | -- | -- | 0.5868 | -1.74 | -1.74 | 1.18 | -1.27 | 2.12 | 1.67 | 8.08 | 222,624.00 | -248.61 | -269.25 | -- | -- | 71.89 | 58.93 | -117.41 | -258.94 | 0.106 | -0.6408 | -- | -- | 25.15 | 97.82 | 23.57 | -- | -- | -- |
Sigyn Therapeutics Inc | 0.00 | -3.70m | 7.27m | 5.00 | -- | -- | -- | -- | -3.08 | -3.08 | 0.00 | -2.91 | 0.00 | -- | -- | 0.00 | -1,085.72 | -493.15 | -- | -- | -- | -- | -- | -10,223.96 | 0.0247 | -2.09 | -- | -- | -- | -- | -41.51 | -- | -- | -- |
Nexalin Technology Inc | 150.16k | -5.40m | 7.35m | 6.00 | -- | 3.90 | -- | 48.94 | -0.7261 | -0.7261 | 0.0202 | 0.1781 | 0.0446 | 0.1679 | 11.53 | 25,026.67 | -160.37 | -- | -202.23 | -- | 82.94 | -- | -3,598.50 | -- | 4.89 | -- | 0.00 | -- | -91.62 | -- | -173.80 | -- | -- | -- |
Agape ATP Corp | 1.38m | -2.45m | 7.39m | 21.00 | -- | 2.29 | -- | 5.36 | -0.6396 | -0.6396 | 0.3599 | 0.8366 | 0.4464 | 8.25 | 36.66 | 65,621.91 | -78.78 | -- | -111.56 | -- | 64.23 | -- | -176.47 | -- | 4.66 | -- | 0.0225 | -- | -22.92 | -- | -24.61 | -- | -- | -- |
ALR Technologies Inc | 9.49k | -8.00m | 7.94m | 6.00 | -- | -- | -- | 837.02 | -0.0147 | -0.0147 | 0.00002 | -0.0476 | 0.0358 | -- | -- | 1,581.67 | -3,015.28 | -12,861.64 | -- | -- | 62.49 | -- | -84,283.24 | -406,011.30 | -- | -0.8626 | -- | -- | -- | -- | -42.72 | -- | -- | -- |
Neurometrix Inc | 4.38m | -7.94m | 7.96m | 26.00 | -- | 0.4578 | -- | 1.82 | -5.50 | -5.50 | 2.91 | 8.58 | 0.2102 | 1.15 | 8.53 | 168,600.80 | -38.06 | -23.24 | -40.80 | -27.26 | 60.19 | 59.17 | -181.03 | -48.88 | 10.71 | -- | 0.00 | -- | -28.52 | -18.18 | -47.84 | -- | 5.03 | -- |
Bioelectronics Corp | 1.61m | -289.82k | 8.65m | 9.00 | -- | -- | -- | 5.37 | -0.00002 | -0.00002 | 0.00007 | -0.0006 | 6.32 | 9.20 | 14.53 | -- | -113.86 | -383.59 | -- | -- | 49.43 | 51.48 | -18.01 | -143.48 | 0.0099 | -0.4909 | -- | -- | 94.01 | -5.09 | 75.01 | -- | -- | -- |
Guided Therapeutics Inc | 38.00k | -2.39m | 9.05m | 4.00 | -- | -- | -- | 238.11 | -0.0444 | -0.0444 | 0.0007 | -0.0829 | 0.0211 | 0.0365 | 8.44 | 9,500.00 | -120.81 | -136.13 | -- | -- | 42.11 | 29.39 | -5,721.05 | -3,666.67 | 0.0679 | -7.58 | -- | -- | 653.85 | 11.45 | 24.40 | -- | -- | -- |
Dror Ortho-Design Inc | 0.00 | -5.63m | 9.41m | 4.00 | -- | 5.68 | -- | -- | -0.012 | -0.012 | 0.00 | 0.0034 | 0.00 | -- | -- | -- | -577.48 | -140.50 | -1,394.24 | -- | -- | -- | -- | -118,188.00 | -- | -- | 0.00 | -- | -- | -- | -1,896.02 | -- | -- | -- |
Precipio Inc | 16.72m | -3.83m | 9.90m | 51.00 | -- | 0.8103 | -- | 0.5921 | -2.68 | -2.68 | 11.73 | 8.24 | 0.9089 | 17.12 | 16.80 | 327,843.10 | -20.82 | -44.98 | -27.94 | -58.68 | 39.08 | 28.80 | -22.90 | -118.07 | 0.590 | -192.59 | 0.0517 | -- | 61.46 | 39.62 | 52.04 | -- | 5.37 | -- |
Vivos Therapeutics Inc | 14.02m | -12.05m | 10.48m | 114.00 | -- | 1.65 | -- | 0.7472 | -6.98 | -6.98 | 6.88 | 1.87 | 0.9477 | -- | 38.84 | 123,000.00 | -81.41 | -89.72 | -166.05 | -149.70 | 60.08 | 70.20 | -85.90 | -113.15 | -- | -- | 0.00 | -- | -13.87 | 29.48 | 43.04 | -- | -8.48 | -- |
Bionoid Pharma Inc | 0.00 | 1.35m | 10.80m | 13.00 | 0.1764 | -- | 7.98 | -- | 1.13 | 1.13 | 0.00 | -0.1744 | -- | -- | -- | -- | -- | -506.64 | -- | -- | -- | -- | -- | -- | -- | 327.24 | -- | -- | -- | -- | -31.55 | -- | 26.01 | -- |
PetVivo Holdings Inc | 975.28k | -10.11m | 11.00m | 20.00 | -- | 13.20 | -- | 11.28 | -0.6705 | -0.6705 | 0.062 | 0.0417 | 0.3257 | 0.405 | 16.37 | 48,764.00 | -337.63 | -230.77 | -589.09 | -467.99 | 83.60 | 66.21 | -1,036.50 | -1,501.44 | 0.455 | -1,075.05 | 0.0221 | -- | 5.62 | -- | -25.67 | -- | 23.91 | -- |
Scientific Industries Inc | 10.45m | -7.76m | 12.29m | 63.00 | -- | 1.05 | -- | 1.18 | -0.9231 | -0.9231 | 1.17 | 1.11 | 0.7343 | 1.13 | 9.08 | 165,942.90 | -54.50 | -- | -62.11 | -- | 45.41 | -- | -74.22 | -- | 3.15 | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- |
Dalrada Financial Corporation | 32.16m | -21.34m | 12.62m | 0.00 | -- | 1.43 | -- | 0.3924 | -0.2388 | -0.2388 | 0.3573 | 0.091 | 1.09 | 8.86 | 3.37 | -- | -75.10 | -80.63 | -239.06 | -- | 30.11 | 39.23 | -68.78 | -63.94 | 1.24 | -21.54 | 0.3452 | -- | 54.35 | -- | -43.94 | -- | -- | -- |
Holder | Shares | % Held |
---|---|---|
Kennedy Capital Management LLCas of 31 Mar 2024 | 40.96k | 2.79% |
The Vanguard Group, Inc.as of 31 Mar 2024 | 35.52k | 2.42% |
BlackRock Fund Advisorsas of 31 Mar 2024 | 28.91k | 1.97% |
Geode Capital Management LLCas of 30 Jun 2024 | 15.16k | 1.03% |
Tower Research Capital LLCas of 31 Mar 2024 | 817.00 | 0.06% |
Wells Fargo Advisors Financial Network LLCas of 31 Mar 2024 | 550.00 | 0.04% |
The Retirement Group LLC (California)as of 31 Mar 2024 | 340.00 | 0.02% |
Osaic Wealth, Inc. (Investment Management)as of 31 Mar 2024 | 110.00 | 0.01% |
UBS Securities LLCas of 31 Mar 2024 | 60.00 | 0.00% |
Wells Fargo Bank, NA (Private Banking)as of 31 Mar 2024 | 11.00 | 0.00% |